James M Demesa insider trades: ONCOSEC MEDICAL (ONCS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 20, 2018 | ONCS | ↑ Buy | 8,500 | $0.82 | $7K | Direct | Nov 26, 2018 (6d) |
| Mar 1, 2011 | ONCS.D | ↑ Buy | 250,000 | $0.00 | $75 | Direct | Mar 24, 2011 (23d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James M Demesa's insider trades
James M Demesa is a director at ONCOSEC MEDICAL (ONCS). Since Mar 1, 2011, James has reported 2 open-market purchases worth $7K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.